Nerve-Centric Endometriosis: Why the Pain Lives in the Nerves, Not Just the Lesions

A histopathology-driven look at neurocentric endometriosis — and why it changes how we think about surgery, recurrence, and chronic pelvic pain.

The Old Model of Endometriosis is Breaking Down

For decades, endometriosis was described in the simplest possible terms: ectopic or aberrant endometrial-like tissue, with pain blamed on prostaglandins, inflammation, and the mechanical mass effect of the lesions themselves. It was a tidy story. It was also incomplete.

Anyone who treats this disease long enough runs into the same stubborn clinical observations that the classic model simply cannot explain:

• Pain severity doesn’t correlate with lesion size. A 2 mm peritoneal lesion can put a patient on the floor. A 5 cm endometrioma can be entirely silent.

• Deep infiltrating lesions are disproportionately painful relative to their inflammatory profile.

• Inflammation and fibrosis alone cannot explain hyperalgesia. If these lesions were simply scar tissue, they should be less sensitive, not more. True scar tissue is typically poorly innervated.

• Pain persists or recurs despite complete excision and despite intense hormonal suppression.

Something structural has been missing from the conversation. That something is the nervous system—and a growing body of evidence suggests that endometriosis is best understood as a nerve-centric, or neurocentric, disease.

---

The Turning Point: Endometriosis Grows Its Own Nerves

Between 2002 and 2006, a series of experimental studies began quietly rewriting the pathology textbook. Tokushige and colleagues demonstrated, for the first time in a reproducible way, that endometriotic lesions—and the eutopic endometrium of women with endometriosis—contain a markedly increased density of small nerve fibers, including unmyelinated sensory C-fibers, the classic nociceptors of chronic pain.

Using immunostains for:

• PGP9.5 (protein gene product 9.5, a pan-neuronal marker)

• Neurofilament (myelinated fibers)

• Substance P and CGRP (sensory neuropeptides)

• Tyrosine hydroxylase (sympathetic fibers)

• Vesicular acetylcholine transporter (cholinergic fibers)

These groups showed that lesions are not just inflamed implants—they are innervated tissue. Critically, this nerve ingrowth was paralleled by the upregulation of nerve growth factor (NGF) and its receptors, the core molecular machinery of nerve sprouting.

The findings were then reproduced across models and tissues: in baboon endometriosis, in human peritoneal lesions, in ovarian endometriomas, and in rectovaginal and rectosigmoid deep nodules. Then, in 2009, Mechsner’s group at the Charité in Berlin demonstrated that nerve fiber density correlates directly with pain severity, and that even peritoneal biopsies—the “superficial” disease—contain small-fiber innervation.

Around the same time, the concept of neuroangiogenesis was formalized: the biological coupling of new blood vessel growth and new nerve growth, driven by the same inflammatory milieu. From that moment forward, the innervation of endometriosis could no longer be dismissed as incidental.

Commentary — Dr. Andrea Vidali, MD

“In the operating room, this evidence lines up with what we’ve seen clinically for years. Patients whose pain is wildly out of proportion to the ‘amount’ of disease, patients with continuing pain after what looked like a clean excision, patients whose pain roars back on hormonal suppression—they are not imagining it, and they are not outliers. They are telling us that the disease has recruited the nervous system, and that the nervous system has its own biology, its own memory, and its own timeline of healing. Any surgeon who still equates ‘lesion gone’ with ‘pain gone’ is working from a 20-year-old model.”

---

What We Actually See Under the Microscope

On routine H&E staining, peripheral nerve fibers within lesions are easy to miss—especially the small, unmyelinated sensory fibers that matter most for pain. The nerves reveal themselves only when we stain specifically for them.

With immunohistochemistry against nerve-specific proteins (PGP9.5, synaptophysin, MAP2, and S100), a consistent picture emerges across subtypes of the disease:

• Deep infiltrating nodules are densely innervated, with nerves running into and through the fibrotic core.

• Peritoneal lesions, long considered “superficial,” show the same pattern: sparse innervation in the adjacent non-endometriotic peritoneum, and a marked increase in neural fibers inside the lesion itself.

• Ovarian and diaphragmatic/thoracic lesions show the exact same phenomenon.

Importantly, these nerves are not randomly scattered through the tissue. They are structurally integrated—tightly associated with glands, stroma, and fibrotic bands, often embedded within the fibrotic core of deep nodules. This is the signature of organization, not accident.

It reframes the role of fibrosis itself. In a nerve-centric model, fibrosis is not a scar—it’s a scaffold. It is the structural matrix that anchors and protects the aberrant neural network the lesion has built.

---

These Nerves Are Alive, Hormone-Sensitive, and Actively Remodeling

The innervation of endometriosis is not passive or static. The molecular environment of the lesion reads like a nerve-growth laboratory:

• Neurotrophins (NGF, BDNF, neurotrophin-3 and -4) are heavily upregulated.

• Neuropeptides (substance P, CGRP) are expressed and released locally.

• Glial-derived neurotrophic factor (GDNF) and neuronal guidance molecules are present, directing ongoing axonal sprouting.

• Serum BDNF is elevated in women with endometriosis, suggesting a systemic fingerprint of the local process.

Layered on top of this is a second biology: hormone-sensitive neuroinflammation.

Under the microscope, macrophages cluster in and around the nerves of endometriotic tissue, and those macrophages are estrogen receptor–positive. This is not generic inflammation. It is a local immune-neural dialogue, modulated by estrogen in real time.

Even on H&E stains of thoracic and diaphragmatic endometriosis specimens, large peripheral nerves can be seen infiltrated by endometrial stromal cells. Those stromal cells travel in the company of macrophages, cytotoxic T cells, and natural killer cells—often migrating along and into nerve trunks.

This confirms that endometriosis is a migratory, immune-competent, hormonally driven process that actively engages the peripheral nervous system. It explains why a negative surgical margin on routine pathology is not the same thing as clearing the disease from the nerve: stromal cells can travel along and around nerves in patterns that a standard specimen simply won’t capture.

---

The Vicious Loop: How Neurocentric Endometriosis Sustains Itself

When you integrate these observations, a self-reinforcing cycle comes into focus:

1. Estrogen activates and recruits immune cells (especially macrophages) into the lesion microenvironment.

2. Immune cells release cytokines and neurotrophic factors (like NGF).

3. Neurotrophic factors drive nerve sprouting—new sensory, sympathetic, and parasympathetic fibers grow directly into the lesion.

4. Nerves release neuropeptides (substance P, CGRP) that in turn promote fibrosis and vasodilation.

5. Fibrosis stabilizes and scaffolds the neural network, sensitizing it further.

Repeat this cycle, monthly, for years.

Over time, this loop drives not only peripheral sensitization at the lesion itself, but central sensitization in the dorsal root ganglia and spinal cord. This is exactly why long-standing endometriosis pain eventually becomes acyclical (no longer tracking the menstrual cycle), and why it can persist long after the visible disease is gone.

Commentary — Dr. Andrea Vidali, MD

“This is the part patients and families most need to understand. Endometriosis pain is not ‘all in the pelvis’ and it is not ‘all in the head.’ It is built into a circuit that runs from an estrogen-sensitive lesion, through inflamed nerves, into the spinal cord and brain—and that circuit gets stronger the longer it runs. That’s the real cost of diagnostic delay. It’s also why I am such an uncompromising advocate for complete, wide excision, addressed early—not ablation, not ‘seeing what grows back.’ You are not just removing tissue. You are trying to break a loop before it wires itself in permanently.”

---

Clinical Implications: Why Surgery Isn’t Enough on Its Own

If nerves are an integral component of endometriotic lesions, several clinical realities immediately follow:

1. A “clean margin” on the specimen is not necessarily a clean margin on the nerve. Perineural and intraneural stromal cell migration can extend beyond what the surgeon sees. This is why meticulous, wide excision by experienced neuropelviology specialists consistently outperforms conservative approaches for durable pain relief.

2. Persistent pain after complete excision is biologically real. It doesn’t mean the surgery “failed” and it doesn’t mean the patient is imagining it. It means the neural arm of the disease (central sensitization, neurogenic inflammation) has its own trajectory and needs targeted treatment.

3. Hormonal suppression is not “treating endometriosis” at the nerve level. It may quiet cyclical, estrogen-driven inflammation, but once acyclical pain is established, suppression alone is typically insufficient.

4. The future of treatment is mechanism-based and multidisciplinary. Excision addresses the lesion. Pelvic floor physical therapy, neuromodulation, targeted pharmacology, and management of central sensitization address the nervous system. These are not alternatives to surgery—they are necessary complements to it.

---

Take-Home Messages

• Endometriosis is not only an ectopic-tissue disease or an inflammatory disease; it is a neurogenic, nerve-centric disease.

• Endometriotic lesions contain their own nerves, structurally integrated with the glands, stroma, and fibrosis of the lesion.

• Fibrosis is best understood as a scaffold, not a scar.

• A self-sustaining estrogen → immune → nerve → fibrosis loop drives chronic, progressively acyclical pain.

• The best clinical outcomes come from combining expert wide excision with nervous-system-directed care.

Final Commentary — Dr. Andrea Vidali, MD

“The shift from ‘endometriosis is misplaced tissue’ to ‘endometriosis is a nerve-centric, neuroinflammatory disease’ is not an academic update. It is a better explanation of what patients have been telling us all along, and it is the foundation for actually curing—not just managing—this disease. Every patient deserves a team that understands that.”

---

References

• Tokushige N, Markham R, Russell P, Fraser IS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Human Reproduction. 2006;21(3):782–787.

• Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Human Reproduction. 2006;21(11):3001–3007.

• Tokushige N, Markham R, Russell P, Fraser IS. Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertility and Sterility. 2007;88(4):795–803.

• Tokushige N, Markham R, Russell P, Fraser IS. Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis. Fertility and Sterility. 2008;90(5):1589–1598.

• Anaf V, Simon P, El Nakadi I, et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Human Reproduction. 2002;17(7):1895–1900.

• Mechsner S, Kaiser A, Kopf A, Gericke C, Ebert A, Bartley J. A pilot study to evaluate the clinical relevance of endometriosis-associated nerve fibers in peritoneal endometriotic lesions. Fertility and Sterility. 2009;92(6):1856–1861.

• Arnold J, Barcena de Arellano ML, Rüster C, et al. Imbalance between sympathetic and sensory innervation in peritoneal endometriosis. Brain, Behavior, and Immunity. 2012;26(1):132–141.

• Asante A, Taylor RN. Endometriosis: the role of neuroangiogenesis. Annual Review of Physiology. 2011;73:163–182.

• Miller EJ, Fraser IS. The importance of pelvic nerve fibers in endometriosis. Women’s Health. 2015;11(5):611–618.

• Barcena de Arellano ML, Arnold J, Vercellino GF, Chiantera V, Schneider A, Mechsner S. Influence of nerve growth factor in endometriosis-associated symptoms. Reproductive Sciences. 2011;18(12):1202–1210.

• Velho RV, Sehouli J, Mechsner S. Mechanisms of peripheral sensitization in endometriosis patients with peritoneal lesions and acyclical pain. Archives of Gynecology and Obstetrics. 2023;308(4):1327–1340.

• Greaves E, Horne AW, Jerina H, et al. Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis. American Journal of Pathology. 2015;185(8):2286–2297.

• Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017;209:8–13.

• Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Frontiers in Cellular Neuroscience. 2020;14:590823.

• Wu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. Journal of Neuroinflammation. 2017;14:53.